Stock 688606 HANGZHOU ALLTEST BIOTECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hangzhou Alltest Biotech Co., Ltd.

Equities

688606

CNE1000053G6

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
56.63 CNY -0.65% Intraday chart for Hangzhou Alltest Biotech Co., Ltd. -0.53% -17.45%
Apr. 29 China, HK stocks rise, led by property shares RE
Apr. 26 Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Hangzhou Alltest Biotech Co Ltd is a China-based company mainly engaged in the development and production of in vitro diagnostic reagents. The Company’s main products are rapid diagnostic reagents, including drug and drug abuse testing, infectious disease testing, women’s health testing, tumor testing, and heart marker testing. The Company's products are widely used in clinical testing, on-site testing and personal health management, especially in some new drug testing, new coronavirus testing, tropical infectious disease testing, respiratory all-in-one inspection, pediatric diarrhea all-in-one inspection and all-in-one joint inspection of fecal occult blood and other fields. The Company's main business is mainly distributed in overseas regions.

Number of employees: 1,093

Sales per Business

CNY in Million2022Weight2023Weight Delta
Infectious Diseases
36.5 %
- - 275 36.5 % -
Drug and Substance Abuse
27.0 %
- - 204 27.0 % -
COVID-19 Testing
11.8 %
- - 89 11.8 % -
Other
10.6 %
- - 80 10.6 % -
Women's Health
9.4 %
- - 71 9.4 % -
Tumor
2.6 %
- - 20 2.6 % -
Cardiac Muscle
1.8 %
- - 13 1.8 % -
Other Business
0.3 %
- - 2 0.3 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
Abroad
92.3 %
2,682 79.2 % 695 92.3 % -74.11%
China
7.7 %
705 20.8 % 58 7.7 % -91.81%

Managers

Managers TitleAgeSince
Fei Gao CEO
 Chief Executive Officer 50 14-06-30
Yan Ping Fu DFI
 Director of Finance/CFO 46 14-06-30
Wei Ke Lu COO
 Chief Operating Officer 43 14-03-31
Fen Fen Qian BRD
 Director/Board Member 44 14-05-31
Yue Can Gao BRD
 Director/Board Member 52 14-02-28
Xiao Ying Chen AUD
 Comptroller/Controller/Auditor 44 14-06-30

Members of the board

Members of the board TitleAgeSince
Fei Gao CEO
 Chief Executive Officer 50 14-06-30
Hua Fang Zhao BRD
 Director/Board Member 50 14-09-30
Wei Ke Lu COO
 Chief Operating Officer 43 14-03-31
Xiao Ying Chen AUD
 Comptroller/Controller/Auditor 44 14-06-30
Yue Can Gao BRD
 Director/Board Member 52 14-02-28
Fen Fen Qian BRD
 Director/Board Member 44 14-05-31
Yan Ping Fu DFI
 Director of Finance/CFO 46 14-06-30
Zhanwang Zheng BRD
 Director/Board Member 49 Nov. 22
Yali Zhou BRD
 Director/Board Member 63 Nov. 22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 79,280,855 26,384,617 ( 33.28 %) 1,621,313 ( 2.045 %) 33.28 %

Shareholders

NameEquities%Valuation
Guotai Asset Management Co., Ltd.
11.91 %
4,459,571 11.91 % 41 M ¥
Jian Ming Xu
11.62 %
4,352,243 11.62 % 40 M ¥
Wei Ke Lu
6.915 %
2,590,000 6.915 % 24 M ¥
Yan Ping Fu
2.766 %
1,036,000 2.766 % 10 M ¥
Fullgoal Fund Management Co., Ltd.
1.650 %
618,105 1.650 % 6 M ¥
GF Fund Management Co., Ltd.
1.091 %
408,749 1.091 % 4 M ¥
China Merchants Fund Management Co., Ltd.
0.7892 %
295,609 0.7892 % 3 M ¥
Da Cheng Fund Management Co., Ltd.
0.5425 %
203,222 0.5425 % 2 M ¥
Maxwealth Fund Management Co., Ltd.
0.2823 %
105,728 0.2823 % 970 919 ¥
Wanjia Asset Management Co., Ltd.
0.2728 %
102,200 0.2728 % 938 521 ¥

Company contact information

Hangzhou Alltest Biotech Co., Ltd.

Workshop 2, 3-4/F, Factory Building 550 Yinhai Street, Baiyang Street

310018, Hangzhou

+

http://www.alltests.com.cn
address Hangzhou Alltest Biotech Co., Ltd.(688606)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Diagnostic & Testing Substances

Sales per Business

Sales per region

Sector Diagnostic & Testing Substances

1st Jan change Capi.
HANGZHOU ALLTEST BIOTECH CO., LTD. Stock Hangzhou Alltest Biotech Co., Ltd.
-17.45% 610M
BIOMÉRIEUX Stock bioMérieux
-6.41% 12.2B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-4.07% 8.22B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+5.77% 5.72B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+28.13% 5.42B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-59.44% 2.7B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+8.04% 2.63B
VITROLIFE AB Stock Vitrolife AB
-6.47% 2.38B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+21.84% 2.1B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.15% 1.81B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 688606 Stock
  4. Company Hangzhou Alltest Biotech Co., Ltd.